Journal Title：Nature Reviews Urology

Nature Reviews' basic, translational and clinical content is written by internationally renowned basic and clinical academics and researchers and targeted towards readers in the biological and medical sciences, from postgraduate level upwards. While intended to be read by practising doctors, researchers and academics within a specialty, we aim to make all our articles accessible to readers working in any biological or medical discipline.

In-depth Reviews present authoritative, up-to-date information on a topic, placing it in the context of a field's history and development. Topical discussion and opinions are proffered in Perspectives and News & Views articles, and in the Research Highlights section we filter primary research from a range of specialty and general medical journals.

Subjects Covered:

-Andrology-

Benign prostatic hyperplasia-

Biostatistics and clinical trials-

Bladder cancer-

Endourology and stones-

Female urology-

Fertility and infertility-

Imaging and radiology-

Infection-

Inflammation-

Pathology-

Paediatric urology-

Penile cancer-

Prostate cancer-

Renal cancer-

Reproductive biology-

Risk factors and epidemiology-

Sexual dysfunction-

Sexual psychology-

Surgery-

Testicular cancer-

Transplantation-

Trauma and reconstruction-

Upper tract urothelial carcinoma-

Upper urinary tract dysfunction-

Urinary incontinence, urodynamics and lower urinary tract dysfunction-

Urologic oncology.

《自然評論》的基礎、轉化和臨床內容由國際知名的基礎和臨床學者和研究人員撰寫，面向生物和醫學科學領域的讀者，從研究生以上水??平。雖然我們旨在供專業內的執業醫生、研究人員和學者閱讀，但我們的目標是讓所有生物或醫學學科的讀者都能閱讀我們的文章。

深入評論提供關于某個主題的權威、最新信息，將其置于該領域的歷史和發展背景中。 “觀點”和“新聞與觀點”文章中提供了專題討論和觀點，在“研究亮點”部分，我們從一系列專業和一般醫學期刊中篩選出主要研究。

涵蓋的主題：

-男科學-

良性前列腺增生-

生物統計學和臨床??試驗-

膀胱癌-

腔內泌尿外科和結石-

女性泌尿外科-

生育和不孕癥-

影像學和放射學-

感染-

炎癥-

病理學-

小兒泌尿外科-

陰莖癌-

前列腺癌-

腎癌癥-

生殖生物學-

風險因素和流行病學-

性功能障礙-

性心理學-

手術-

睪丸癌-

移植-

創傷和重建-

上尿路上皮癌-

上尿路功能障礙-

尿失禁、尿動力學和下尿路功能障礙-

泌尿腫瘤學。

Nature Reviews Urology創刊于2009年，由Springer Nature出版商出版，收稿方向涵蓋醫學 - 泌尿學與腎臟學全領域，在行業領域中學術影響力很大，屬于TOP期刊，國際一流期刊，關注度和專業度非常高，所以對原創文章要求創新性很高，過審難度很高，如果您有志于TOP期刊，建議關注此刊。平均審稿速度 較慢,6-12周 ，影響因子指數12.1，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。